Molecular monitoring of imatinib in chronic myeloid leukemia patients in complete cytogenetic remission: Does achievement of a stable major molecular response at any time point identify a privileged group of patients? A multicenter experience in Argentina and Uruguay

1. Pavlovsky, C.
2. Giere, I.
3. Moiraghi, B.
4. Pavlovsky, M.A.
5. Aranguren, P.N.
6. García, J.
7. Fernandez, I.
8. Bengió, R.
9. Milone, J.
10. Labanca, V.
11. Uriarte, R.
12. Lombardi, V.
13. Reinoso, F.G.
14. Magarios, A.E.
15. Martinez, L.
16. Murro, H.
17. Lastiri, F.
18. Pavlovsky, S.